Hemacare Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2012
2015
2016
2017
2018
Sales/Revenue
17,911.00
9,702.00
13,876.00
20,212.00
28,506
Cost of Goods Sold (COGS) incl. D&A
14,776.00
5,292.00
6,751.00
9,594.00
12,840
Gross Income
3,135.00
4,410.00
7,125.00
10,618.00
15,666
SG&A Expense
3,870.00
5,790.00
6,326.00
7,195.00
9,434
EBIT
735.00
1,380.00
799.00
3,423.00
6,232
Pretax Income
735.00
1,380.00
799.00
3,423.00
6,232
Income Tax
23.00
22.00
18.00
1,009.00
1,716
Consolidated Net Income
758.00
1,402.00
781.00
4,432.00
4,516
Net Income
758.00
1,402.00
781.00
4,432.00
4,516
Net Income After Extraordinaries
2,679.00
6,040.00
781.00
4,432.00
4,516
Net Income Available to Common
1,163.00
1,160.00
781.00
4,432.00
4,516
EPS (Basic)
0.11
0.30
0.07
0.37
0.35
Basic Shares Outstanding
10,331.50
10,747.80
10,747.80
12,011.50
12,861
EPS (Diluted)
0.11
0.30
0.07
0.37
0.35
Diluted Shares Outstanding
10,331.50
10,747.80
10,747.80
12,011.50
12,861
EBITDA
30.00
980.00
1,202.00
3,798.00
6,703

About Hemacare

View Profile
Address
15350 Sherman Way
Van Nuys California 91406
United States
Employees -
Website http://www.hemacare.com
Updated 07/08/2019
HemaCare Corp. engages in the provision of bioresearch products and services for customer's research and cell therapy protocols. It offers human derived primary blood cells and tissues for biomedical research, supported cell therapy clinical trials and commercialization with apheresis collections, and provides a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company was founded in 1978 and is headquartered in Van Nuys, CA.